Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02679287 · ClinicalTrials.gov registry record · NA
Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT02679287 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 103 participants.
The verdict
NCT02679287, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
The purpose of this study is to use an investigational type of technology called Closed-Loop Control (CLC) Medical Platform System to help control blood sugar in people with type 1 diabetes mellitus in a home setting.
Interventions
- DEVICE CLC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02679287
The ClinicalTrials.gov registry entry for NCT02679287 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CLC is the first listed.
NCT02679287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02679287 about?
NCT02679287 is a clinical study titled "Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control". The purpose of this study is to use an investigational type of technology called Closed-Loop Control (CLC) Medical Platform System to help control blood sugar in people with type 1 diabetes mellitus in a home setting.
What is the current status of trial NCT02679287?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2016-02. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02679287?
The interventions under investigation include: CLC (DEVICE).
Who is sponsoring clinical trial NCT02679287?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.